好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Trial of Peer Leaders In Neurology 好色先生 (TOPLINE): Interim Data Analysis from a Multicenter Randomized Controlled Non-inferiority Trial of Near-peer Teachers in Neurology Simulation
好色先生, Research, and Methodology
P7 - Poster Session 7 (8:00 AM-9:00 AM)
15-014

To determine if near-peer debriefing results in resident performance outcomes that are non-inferior to those of residents debriefed by experienced faculty educators in a simulated status epilepticus case.

Limited faculty time is a barrier to implementing simulation training in neurology. Using near-peer facilitators has been proposed as a strategy to mitigate this challenge. However, whether learners debriefed by near-peers have similar outcomes to those debriefed by faculty is a gap in the literature.

This is a pre-specified interim data analysis of a multicenter, randomized control trial. Participants were junior neurology residents (adult PGY2 or pediatric PGY3) recruited from four academic centers. Following pre-briefing, residents’ performance was measured on a critical action checklist from a previously reported simulated status epilepticus case (the “pre-test”). Participants were randomized to receive one-on-one debriefing by a near-peer (intervention group) or faculty member (control group) using Debriefing with Good Judgement. Participants engaged in distraction learning before managing a second case of simulated status epilepticus (the “post-test”). The primary outcome was the change in percent of critical actions completed correctly from the pre- to the post-test.

Sample size calculation yielded a required 46 participants for 80% power to detect non-inferiority with a margin of 10%. After one year of recruitment, 27 junior neurology residents were enrolled. After debriefing, participant performance improved by 6.4% (p=0.011) in the intervention group and by 11.5% (p<0.001) in the control group. The improvement in performance in the intervention group was not non-inferior to the improvement in the control group (difference of the means 5.1%, CI -11.8% - 1.6%).

Improvement in checklist-based performance fostered by near-peer debriefers was not non-inferior to improvement fostered by faculty debriefers. The interim analysis is likely underpowered to detect non-inferiority; enrollment is ongoing. Our methodology, investigation, and analysis may inform future multicenter randomized control trials in neurology education.

Authors/Disclosures
Paulina Henriquez, MD
PRESENTER
Dr. Henriquez has nothing to disclose.
Galina Gheihman, MD (Brigham & Women's Hospital) Dr. Gheihman has nothing to disclose.
Yara Mikhaeil-Demo, MD (Northwestern University, Feinberg School of Medicine) Dr. Mikhaeil-Demo has nothing to disclose.
Salma Said Elkolaly, MD (Missouri University Hospitals) Dr. Elkolaly has nothing to disclose.
Rose C. Healy, MD (Boston Medical Center) Miss Healy has nothing to disclose.
Zachary T. Lazzari, MD Dr. Lazzari has nothing to disclose.
Rameez A. Merchant, MBBS Dr. Merchant has nothing to disclose.
Sarah C. Parauda, MD (Westchester Medical Center) Dr. Parauda has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Panter, Panter & Sampedro.
Terry Park, MD (Westchester Medical Center) Dr. Park has nothing to disclose.
Sean L. Thompson (Emory University School of Medicine) Dr. Thompson has nothing to disclose.
Nicholas A. Morris, MD, FAAN (University of Maryland Medical Center) The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from 好色先生. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with 好色先生 that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to AAN interests or activities.
Casey S. Albin, MD, FAAN (Emory Healthcare) Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from 好色先生. Dr. Albin has received publishing royalties from a publication relating to health care.
Daniel S. Harrison, MD (Boston Medical Center) Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Diedrich & Donohue, LLP.